Pazopanib Tablets
Pharmaceutical Form: Tablet
Strength/Pack: 200 mg
Pazopanib tablets are oral, targeted anticancer agents indicated as a monotherapy for patients with progressive renal cell carcinoma (Kidney Cancer). Patients with advanced soft tissue sarcoma who have already received chemotherapy are also treated with it. The aim of this medicine is to delay progression, manage tumor growth, and increase survival rate. It targets multiple kinases and receptors that help in the growth of cancer tissue. Pazopanib suppresses new blood vessel formation and directly affects tumor cell proliferation.